To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3418 | Mlt-695 |
Novel potent and selective MALT-1 protease inhibitor, showing improved solubility and permeability in comparison with MLT-748
More description
|
|
| DCC3417 | Ml-sa3 |
Potent agonist of TRPML channels specifically activating lysosomal ML1 currents
More description
|
|
| DCC3416 | Mls8091 |
Novel inhibitor of human cytomegalovirus (HCMV) infection
More description
|
|
| DCC3415 | Mls-2384 |
Novel dual JAK/Src kinase inhibitor, suppressing growth of diverse cancer cells
More description
|
|
| DCC3414 | Mls-2064 |
Potent inhibitor of STAT3 and Akt signaling
More description
|
|
| DCC3413 | Mls001158554 |
Novel Inhibitor of Human Cytomegalovirus
More description
|
|
| DCC3412 | Mls000733230 |
Novel potent inhibitor of EBOV infection
More description
|
|
| DCC3411 | Mls000545091 |
Potent and selective mixed-type inhibitor of human epithelial 15-lipoxygenase-2 (15-LOX-2)
More description
|
|
| DCC3410 | Mls000536924 |
Potent and selective competitive inhibitor of human epithelial 15-lipoxygenase-2 (15-LOX-2)
More description
|
|
| DCC3409 | Mls000099089 |
Novel selective and potent inhibitor of recombinant h12/15-LOX and cellular mouse 12/15-LOX (m12/15-LOX)
More description
|
|
| DCC3408 | Mln-977 |
Second generation 5-LO inhibitor, blocking the production of leukotrienes
More description
|
|
| DCC3407 | Mln944 |
Novel potent DNA binding agent, stabilizing topoisomerase-dependent cleavage, demonstrating exceptional efficacy against a number of murine and human tumor models
More description
|
|
| DCC3406 | Mln-0415 |
Novel IKK2 inhibitor, decreasing NF-κB activation and down-regulating the expression of a number of inflammatory proteins
More description
|
|
| DCC3405 | Mlck Inhibitor Peptide-18 |
Selective inhibitor of Myosin Light Chain Kinase (MLCK)
More description
|
|
| DCC3404 | ml312 |
Novel Inhibitor of Scavenger Receptor BI-mediated Lipid Uptake
More description
|
|
| DCC3403 | Km04794 |
Novel endoplasmic reticulum proteostasis modulator, enhancing insulin production in pancreatic β cells, inhibiting the UPR, alleviating ER stress and protein aggregation, improving intracellular insulin levels and insulin secretion
More description
|
|
| DCC3402 | Mkp5-in-1 |
Novel highly specific, potent, orally bioavailable MKP5 inhibitor
More description
|
|
| DCC3401 | Mkk3/6-in-6 |
Novel potent and selective MKK3/6 inhibitor
More description
|
|
| DCC3400 | Mk-8970 |
Prodrug of raltegravir with enhanced colonic absorption
More description
|
|
| DCC3399 | Mk-8666 Tromethamine |
Novel agonist of G-protein coupled receptor 40 (GPR40)
More description
|
|
| DCC3398 | Mk-8245 Analog |
Novel liver-targeting inhibitor of stearoyl-CoA desaturase (SCD)
More description
|
|
| DCC3397 | Mk-7725 |
Novel bombesin receptor subtype-3 (BRS-3) modulator
More description
|
|
| DCC3396 | Mk-6884 |
Novel potent muscarinic acetylcholine receptor 4 (M4) positive allosteric modulator (PAM)
More description
|
|
| DCC3395 | Mk-5046 |
Novel nonpeptide bombesin receptor subtype-3 agonist
More description
|
|
| DCC3394 | Mk-4541 |
Novel Selective Androgen Receptor Modulator (SARM)
More description
|
|
| DCC3393 | Mk-386 |
Potent and selective human type-1 5alpha-reductase inhibitor
More description
|
|
| DCC3392 | Mk-2295 |
Potent TRPV1 antagonist
More description
|
|
| DCC3391 | Mk-1597 |
Novel renin inhibitor
More description
|
|
| DCC3390 | Mk-1220 |
Novel Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure
More description
|
|
| DCC3389 | Mk-0916 |
Selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor
More description
|
|